Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia

Sanah Sajawal1, Sarah L Mackie2, Peter Hillmen3

  • 1Chapel Allerton Hospital, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

BMJ Case Reports
|November 11, 2017
PubMed